v3.26.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2023 $ 743 $ 470,295 $ (10,776) $ 460,262
Beginning balance (in shares) at Dec. 31, 2023 7,434,955      
Stock-based compensation       1,105,865
Net loss       (1,689,843)
Ending balance at Jun. 30, 2024       (123,717)
Beginning balance at Dec. 31, 2023 $ 743 470,295 (10,776) 460,262
Beginning balance (in shares) at Dec. 31, 2023 7,434,955      
Stock-based compensation       1,138,575
Net loss       (2,910,139)
Ending balance at Sep. 30, 2024       (1,311,303)
Beginning balance at Dec. 31, 2023 $ 743 470,295 (10,776) 460,262
Beginning balance (in shares) at Dec. 31, 2023 7,434,955      
Issuance of restricted stock awards   1,171,286   1,171,286
Stock-based compensation $ 889 (889)    
Stock-based compensation (in shares) 8,885,884      
Net loss     (5,713,369) (5,713,369)
Ending balance at Dec. 31, 2024 $ 1,632 1,640,692 (5,724,145) $ (4,081,821)
Ending balance (in shares) at Dec. 31, 2024 16,320,839     16,320,839
Beginning balance at Jun. 30, 2024       $ (123,717)
Stock-based compensation       32,710
Net loss       (1,220,296)
Ending balance at Sep. 30, 2024       (1,311,303)
Beginning balance at Dec. 31, 2024 $ 1,632 1,640,692 (5,724,145) (4,081,821)
Stock-based compensation       227,673
Net loss       (6,936,475)
Beginning balance at Dec. 31, 2024 $ 1,632 1,640,692 (5,724,145) $ (4,081,821)
Beginning balance (in shares) at Dec. 31, 2024 16,320,839     16,320,839
Stock-based compensation       $ 5,664,449
Issuance of common stock upon conversion of SAFE Notes       53,511,234
Net loss       (52,350,810)
Ending balance at Sep. 30, 2025       29,808,242
Beginning balance at Dec. 31, 2024 $ 1,632 1,640,692 (5,724,145) $ (4,081,821)
Beginning balance (in shares) at Dec. 31, 2024 16,320,839     16,320,839
Issuance of restricted stock awards $ 301 797   $ 1,098
Issuance of restricted stock awards (in Shares) 3,010,401      
Stock-based compensation   6,769,296   6,769,296
Issuance of common stock upon conversion of SAFE Notes $ 1,960 53,509,274   $ 53,511,234
Issuance of common stock upon conversion of SAFE Notes (in shares) 19,601,182     19,601,182
Issuance of common stock to PIPE investors $ 1,000 29,999,000   $ 30,000,000
Issuance of common stock (in shares) 10,000,000      
Offering costs   (2,909,740)   (2,909,740)
Issuance of placement agent warrants (equity component)   948,639   948,639
Issuance costs - placement agent warrants (non-cash)   (948,639)   (948,639)
Issuance of common stock to new shareholders upon merger $ 217 (217)    
Issuance of common stock to new shareholders upon merger (in shares) 2,166,667      
Net loss     (61,002,954) (61,002,954)
Ending balance at Dec. 31, 2025 $ 5,110 $ 89,009,102 $ (66,727,099) $ 22,287,113
Ending balance (in shares) at Dec. 31, 2025 51,099,089     51,099,089
Stock-based compensation       $ 5,436,776
Issuance of common stock upon conversion of SAFE Notes       53,511,234
Net loss       (45,414,335)
Ending balance at Sep. 30, 2025       $ 29,808,242